Grass pollen allergy immunotherapy (BIAL)
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameGrass pollen allergy immunotherapy (BIAL)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBial
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRoxall Medicina España S.A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A